Akoya (AKYA) Gains in Light Trading for June 23

Equities Staff  |

Akoya Biosciences Inc (NASDAQ:AKYA) stock was among today's market movers, concluding trading up 8.89% to $10.53 on June 23.

93,112 shares traded hands while the 30-day daily average of 114,544 shares.

The company's stock has risen 36.84% so far in 2022.

Akoya shares have moved between $8.02 and $21.84 over the past twelve months.

The company expects its next earnings on 2022-08-09.

For technical charts, analysis, and more on Akoya visit the company profile.

About Akoya Biosciences Inc

As The Spatial Biology Company®, Akoya Biosciences’ mission is to bring context to the world of biology and human health through the power of spatial phenotyping. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and treatment response. Akoya offers two distinct solutions, the CODEX® and Phenoptics™ platforms, to serve the diverse needs of researchers across discovery, translational and clinical research.

To get more information on Akoya Biosciences Inc and to follow the company's latest updates, you can visit the company's profile page here: Akoya Biosciences Inc's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Trending Articles

Investors Must Understand 5G Wireless Growth Wave: Jeff Kagan
'Goldilocks' Stocks Will Define This Decade
What You Need To Know About Bear Markets
Is Your iPhone Already Obsolete?



Market Movers

Sponsored Financial Content